Board Meeting

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE232.15-6.85 (-2.87 %)
PREV CLOSE ( ) 239.00
OPEN PRICE ( ) 230.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 39260
TODAY'S LOW / HIGH ( )229.35 236.75
52 WK LOW / HIGH ( )80 254.95
NSE232.65-5.8 (-2.43 %)
PREV CLOSE( ) 238.45
OPEN PRICE ( ) 233.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 232.65 (469)
VOLUME 184834
TODAY'S LOW / HIGH( ) 229.00 236.75
52 WK LOW / HIGH ( )81.9 253.85

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.